Zobrazeno 1 - 10
of 217
pro vyhledávání: '"GEOFFREY T. TUCKER"'
Autor:
Laurence E Mather, Geoffrey T Tucker
Publikováno v:
Regional Anesthesia & Pain Medicine. :rapm-2023
Autor:
Laurence E. Mather, Geoffrey T. Tucker
Publikováno v:
Anesthesiology. 136(4)
Pharmacokinetics of Local Anaesthetic Agents. By Tucker GT, Mather LE. Br J Anaesth 1975; 47(suppl 1):213–24 Information derived from measurements of blood concentrations of local anaesthetics can be extended by the application of pharmacokinetic a
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics. 49(2)
The gamma-Pareto type I convolution (GPC type I) distribution, which has a power function tail, was recently shown to describe the disposition kinetics of metformin in dogs precisely and better than sums of exponentials. However, this had very long r
Publikováno v:
European Journal of Pharmaceutical Sciences. 115:57-67
There is increasing interest in paediatric drug absorption and the development of biopharmaceutics tools to facilitate the development of oral formulations for neonates, infants and children. We describe the development and application of a physiolog
Autor:
Titus Mohan, Michael D. Wiese, Porntipa Korprasertthaworn, Geoffrey T. Tucker, Andrew Rowland, Thomas M. Polasek, Michael J. Sorich, Amin Rostami-Hodjegan, Vidya Perera
Publikováno v:
British Journal of Clinical Pharmacology
Aim: The aim of the present study was to predict olanzapine (OLZ) exposure in individual patients using physiologically based pharmacokinetic modelling and simulation (PBPK M & S). Methods: A 'bottom-up' PBPK model for OLZ was constructed in Simcyp®
Autor:
Nuy Chau, Kushari Burns, John O. Miners, Ross A. McKinnon, Kathleen M. Knights, Andrew Rowland, Geoffrey T. Tucker, Peter I. Mackenzie, Ganessan Kichenadasse
Publikováno v:
Biochemical Pharmacology. 129:85-95
Kinase inhibitors (KIs) are a rapidly expanding class of drugs used primarily for the treatment of cancer. Data relating to the inhibition of UDP-glucuronosyltransferase (UGT) enzymes by KIs is sparse. However, lapatinib (LAP), pazopanib (PAZ), regor
Autor:
Karen Rowland Yeo, Bo Liu, Mahmut Özdemir, Geoffrey T. Tucker, H. Kim Crewe, Amin Rostami-Hodjegan
Publikováno v:
Biopharmaceutics & Drug Disposition. 38:260-270
The impact of different single oral doses of ketoconazole (KTZ) (100, 200 and 400 mg) and of staggering its dosage (400 mg at -12, -2, 0, 2 and 4 h), with respect to the administration of a single 5 mg oral dose of midazolam (MDZ) on the extent of in
Autor:
Geoffrey T. Tucker, Carl A. Wesolowski
Publikováno v:
Br J Clin Pharmacol
Autor:
Geoffrey T. Tucker
Publikováno v:
Pharmaceutical Research
A brief account is given of various approaches to the individualization of drug dosage, including the use of pharmacodynamic markers, therapeutic monitoring of plasma drug concentrations, genotyping, computer-guided dosage using 'dashboards', and aut
Autor:
Daniel Tang, Hanns-Christian Mahler, Michiho Ito, Hitoshi Sasaki, Michael B. Ward, Binodh DeSilva, Don Mager, Anke H. Maitland-van der Zee, Takuya Kumamoto, Geoffrey T. Tucker, Jennifer B. Dressman, Vinod P. Shah, Giovanni M. Pauletti
Publikováno v:
Journal of pharmaceutical sciences, 105(9), 2489-2497. John Wiley and Sons Inc.
The chairs of each of the 8 Special Interest Groups of the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation have compiled opinions with regard to major challenges for the pharmaceutical sciences over the next 5-10 years